What is the price-to-earnings ratio of Soligenix?
The price-earnings ratio of Soligenix is currently -0.18.
Soligenix P/E 2024
Soligenix P/E
-0.18
Ticker
SNGX
ISIN
US8342233074
WKN
A2AS7Q
As of Sep 19, 2024, Soligenix's P/E ratio was -0.18, a -80.22% change from the -0.91 P/E ratio recorded in the previous year.
The Soligenix P/E history
Soligenix Aktienanalyse
What does Soligenix do?
Soligenix Inc. is a biopharmaceutical company specialized in the development of treatment and prevention methods for serious diseases. It was founded in 1987 and is headquartered in Princeton, New Jersey. The business model of Soligenix Inc. is based on the research and development of innovative therapies for diseases that are currently difficult to treat or have no known cure. The company's research and development focus on three core areas: vaccines, cancer therapies, and rare diseases. In the field of vaccines, Soligenix Inc. has focused on developing therapies against biological threats such as anthrax, smallpox, or botulinum toxin-like toxins. These threats are not only a potential danger to national security but can also occur in the form of natural disasters or terrorist attacks. Soligenix Inc. has several promising vaccine candidates in clinical trials, including an anthrax vaccine that works faster and safer than currently available vaccines. In the field of cancer therapy, the company focuses on developing new immunotherapies for the treatment of solid tumors. Soligenix Inc. uses a technology platform called "RiVax" based on the inactivation of botulinum toxin. This platform has already proven promising in redirecting the body's immune system to tumor cells and killing them. As the last core area, the company is dedicated to the treatment of rare diseases that are often overlooked and insufficiently treated. Soligenix Inc. has already developed a promising candidate for the treatment of oropharyngeal candidiasis (fungal infections in the mouth and throat) and is in phase III clinical trials. Overall, Soligenix Inc. has developed a range of promising products in various stages of clinical trials. In addition to the mentioned candidates, the company has also developed a promising treatment for relieving the side effects of cancer chemotherapy. This product called SGX942 is currently in phase III clinical trials. In addition to ongoing clinical studies, Soligenix Inc. has also established strong partnerships with government organizations such as the US National Institutes of Health or the Biomedical Advanced Research and Development Authority (BARDA). These partnerships are important to secure funding for ongoing research projects and allow the company to bring its products to market quickly. Soligenix Inc. has experienced strong growth in recent years and has established itself as a key player in the biopharmaceutical industry. The company has received several awards for its research work and innovation potential in the past and seems to be on a good path to bring further groundbreaking therapies to the market. Soligenix ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Soligenix's P/E Ratio
The Price to Earnings (P/E) Ratio of Soligenix is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Soligenix's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Soligenix is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Soligenix’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Soligenix stock
How has the price-earnings ratio of Soligenix changed compared to last year?
The price-to-earnings ratio of Soligenix has increased by -80.22% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Soligenix high compared to other companies?
Yes, the price-to-earnings ratio of Soligenix is high compared to other companies.
How does an increase in the price-earnings ratio of Soligenix affect the company?
An increase in the price-earnings ratio of Soligenix would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Soligenix affect the company?
A decrease in the price-earnings ratio of Soligenix would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Soligenix?
Some factors that influence the price-earnings ratio of Soligenix are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Soligenix pay?
Over the past 12 months, Soligenix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Soligenix is expected to pay a dividend of 0 USD.
What is the dividend yield of Soligenix?
The current dividend yield of Soligenix is .
When does Soligenix pay dividends?
Soligenix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Soligenix?
Soligenix paid dividends every year for the past 0 years.
What is the dividend of Soligenix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Soligenix located?
Soligenix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Soligenix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Soligenix from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Soligenix pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Soligenix in the year 2023?
In the year 2023, Soligenix distributed 0 USD as dividends.
In which currency does Soligenix pay out the dividend?
The dividends of Soligenix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Soligenix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Soligenix
Our stock analysis for Soligenix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Soligenix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
